Focus on Diabetes

ReachMD

ReachMD takes an in-depth look at diabetes, a disease identified in nearly 1 in 10 Americans, which upsets the lives of millions more. Even more disturbing, the rates of new cases of diagnosed diabetes have risen almost twofold during the past decade. Nutrition, exercise and genetics are all factors in how the disease affects children, adults and the elderly, but that's only the beginning. How are surgical options changing the way we think about the disease? How close are we to a cure for Type 1 diabetes? Are there treatment lessons we can take from community-based initiatives abroad? Tune in to gain insights for your practice.

Location:

United States

Genres:

Medical

Health

Podcasts

Networks:

ReachMD

Description:

ReachMD takes an in-depth look at diabetes, a disease identified in nearly 1 in 10 Americans, which upsets the lives of millions more. Even more disturbing, the rates of new cases of diagnosed diabetes have risen almost twofold during the past decade. Nutrition, exercise and genetics are all factors in how the disease affects children, adults and the elderly, but that's only the beginning. How are surgical options changing the way we think about the disease? How close are we to a cure for Type 1 diabetes? Are there treatment lessons we can take from community-based initiatives abroad? Tune in to gain insights for your practice.

Language:

English

Website:

http://www.reachmd.com/

Episodes

Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy

4/30/2021

Guest: Kevan C. Herold, MD Guest: Chantal Mathieu, MD, PhD Experts in the immunopathology of type 1 diabetes discuss the epidemiology, non-genetic and genetic risk factors, and progression from preclinical to clinical stages of this disease. The discussion will emphasize the breakdown of immune tolerance that precedes type 1 diabetes and the subsequent pathogenetic role of islet autoantibodies responsible for its clinical manifestations.

Duration:00:29:29

Managing Diabetes & COVID-19 in the Wintertime

12/9/2020

Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD The wintertime presents new challenges for patients with chronic diseases, specifically diabetes. But with the spread of COVID-19, how can we help keep our patients safe all winter long? Tune in to hear our Diabetes Discourse hosts Drs. Carol Wysham, John Buse, and John Anderson discuss strategies to effectively manage patients with diabetes during these winter months. Published December X, 2020

Duration:00:10:59

A New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs

3/27/2020

Host: Linda Bernstein, Pharm.D. On this episode of The Drug Report, pharmacist Dr. Linda Bernstein focuses on a recent CVS Health announcement of their new plan that allows employers and health plan sponsors to work within a formulary and plan design to offer all types of diabetes medications—including insulin—at zero-dollar out of pocket for their members without raising costs for the plan sponsor or increasing premiums or deductibles for all plan members.

Duration:00:05:30

A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease

3/27/2020

Host: Linda Bernstein, Pharm.D. In this episode of The Drug Report, pharmacist Dr. Linda Bernstein highlights some diabetes medications that have achieved or are pending approval for new indications pertaining to cardiovascular disease risk reduction.

Duration:00:04:30

Addressing the Unseen Complications of Diabetes

9/15/2019

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize...

Duration:00:16:59

In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy

9/15/2019

Duration:00:16:59

Diabetes Cardiovascular Outcomes Trials: What You Need to Know

8/27/2019

Guest: Michael H. Davidson, MD Tune in as Dr. Michael Davidson, a preventive cardiologist from the University of Chicago Pritzker School of Medicine, outlines what a diabetes cardiovascular outcomes trial (CVOT) is, the differences between CVOTs and glycemic efficacy trials, and how these studies are designed and assessed. US19HCP00067 July 2019

Duration:00:17:59

Role of the Cardiologist in T2D Management

2/26/2019

Host: Jennifer Caudle, DO Guest: Christie Ballantyne, MD With the number of patients with both type 2 diabetes and established cardiovascular disease on the rise, a personalized patient approach to treating these two conditions is now more important than ever. Joining Dr. Jennifer Caudle to discuss the role of the cardiologist in managing patients with type 2 diabetes is Dr. Christie Ballantyne. US18VZ00285 January 2019

Duration:00:07:59

Unmet Clinical Needs for Patients with T2D & Established CVD

2/12/2019

Host: Jennifer Caudle, DO Guest: Mikhail Kosiborod, MD Type 2 diabetes and established cardiovascular disease continues to impact patients and more focus is now set on addressing these patients’ unmet needs. Joining Dr. Jennifer Caudle is cardiologist Dr. Mikhail Kosiborod, who discusses a more reflexive approach to disease management that aims to close this gap in care. US18VZ00284 January 2019

Duration:00:08:59

Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective

2/12/2019

Host: Jennifer Caudle, DO Guest: Mikhail Kosiborod, MD Guest: Christie Ballantyne, MD Since type 2 diabetes and cardiovascular disease often go hand in hand, having a care collaboration plan in place is essential in managing these conditions. Here to discuss both the challenges and opportunities that arise when collaborating patient care are cardiologists Dr. Mikhail Kosiborod and Dr. Christie Ballantyne. US18VZ00286 January 2019

Duration:00:13:29

When Insulin Isn’t Enough: Exploring Dual SGLT1 and SGLT2 Inhibition in T1DM

10/15/2018

Host: Shira Johnson, MD Guest: Anne Peters, MD Guest: Donna Miller, MSN, FNP-C, CDE Guest: Jana Conley This activity explores new and emerging treatments for type 1 diabetes, including a dual sodium glucose transporter 1/2 inhibitor, and provides both clinician and patient perspectives on their use.

Duration:00:19:29

The P4 Approach: Revolutionizing Diabetic Macular Edema

9/25/2018

Host: Rishi P. Singh, MD Guest: Arshad Khanani, MD Guest: Ehud Ur, MD Guest: David Boyer, MD Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options for efficient, accurate and reproducible diagnosis and monitoring of ocular conditions. Likewise, diabetes management guidelines and strategies, including pharmacologic treatments and devices, have also evolved, underscoring the importance of...

Duration:00:53:29

The P4 Approach: Predictive, Preventive, Personalized and Participatory Medicine

9/25/2018

Duration:00:53:29

Is a Low-Carb, High-Fat Diet the Key to Diabetic Management?

3/5/2018

Host: Barnett Mennen, MD Guest: Sarah Hallberg, MD Carbohydrates are our main source of energy and provide important nutrients for good health. However, they are also the main culprit behind elevated blood sugar and are problematic for diabetic patients trying to control their blood sugar levels. Host Dr. Barry Mennen sits down with Dr. Sarah Hallberg to talk about carbohydrate restriction as a key to successful weight loss programs. She prescribes that adherence to a low-carb, high-fat...

Duration:00:11:29

Diabetes and Cardiovascular Risk: New Thinking, New Opportunities

2/28/2018

Host: John J. Russell, MD Guest: John (Jack) L. Leahy, MD Diabetes is a major global health emergency, affecting approximately 415 million adults and contributing to five million deaths each year. Cardiovascular disease is a serious complication of type 2 diabetes mellitus (T2DM), contributing to the majority of morbidity and mortality in this population. In recent years, the cardiovascular impact of anti-diabetes medications has become the focus of research. Recent findings from...

Duration:00:28:29

Improving Glycemic Control: Reducing Patient Burden, The Rationale for Concentrated Insulins in Type 2 Diabetes Mellitus

1/23/2018

Host: John J. Russell, MD Guest: Anne Peters, MD, CDE Many patients with type 2 diabetes mellitus cannot be controlled with standard insulin agents due to obesity, insulin resistance, high risk of hypoglycemia, low adherence due to high injection burden, and the need for frequent glucose monitoring. Drs. Peters and Russell will review patient cases, and share practical information on concentrated insulins, including criteria for selection, switching strategies and dosing regimens,...

Duration:00:14:29

Enhancing Adherence to Maintain Glycemic Control in Patients with Type 2 Diabetes

11/28/2017

Host: Matt T. Rosenberg, MD Guest: Monica E. Peek, MD, MPH, MSC Attaining and maintaining glycemic control continues to be very difficult for patients with type 2 diabetes. Please join Drs. Matt T. Rosenberg and Monica E. Peek as they discuss these issues.

Duration:00:16:00

FDA Confirms Leg and Foot Amputation Risk with Diabetes Medicine Canagliflozin

5/16/2017

Based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (brand names Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. The FDA is requiring new warnings, including their most prominent Boxed Warning, be added to the canagliflozin drug labels to describe this risk. Amputations of the toe and middle of the foot were the most common; however, amputations involving the leg, below and above the...

Duration:00:03:00

The Rising Diabulimia Epidemic: Safeguarding Diabetic Patients with Eating Disorders

12/19/2016

Host: Brian P. McDonough, MD, FAAFP Diabulimia, defined as the manipulation of insulin treatments by Type 1 diabetic patients in order to lose weight, is a rising problem among teens and young adults in the U.S, particularly young women. Joining Dr. Brian McDonough to discuss this dual diagnosis phenomenon of diabetes and eating disorders, ways in which they exacerbate other disease processes, the long term consequences, and management priorities for phycisians is author and registered...

Duration:00:13:30

Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods

5/30/2016

[Read the Article] Despite targeted efforts to reduce obesity through diet and exercise, these rates continue to rise. A new study from Ontario, Canada found that obesity and diabetes rates were lower in more walkable neighborhoods compared to less walkable neighborhoods, where they saw an increase in these rates.Researchers from St. Michael's Hospital in Toronto studied almost 9,000 neighborhoods in Southern Ontario looking at walkability scores, along with government health data and survey...

Duration:00:01:00